Corporate ActionAug 5, 2026, 08:02 AM
AIM ImmunoTech Terminates At-The-Market Equity Agreement
AI Summary
AIM ImmunoTech Inc. has mutually terminated its Equity Distribution Agreement with Maxim Group LLC, effective August 15, 2026. This agreement allowed the company to sell common stock through an "at the market offering." The company will not incur any termination penalties as a result of this termination. From April 1, 2025, to July 31, 2026, AIM ImmunoTech sold 3,200,736 shares for approximately $2.8 million under this agreement.
Key Highlights
- Equity Distribution Agreement with Maxim Group LLC mutually terminated.
- Termination of the agreement is effective August 15, 2026.
- AIM ImmunoTech Inc. will not incur any termination penalties.
- Company sold 3,200,736 shares of common stock under the agreement.
- Generated approximately $2.8 million in aggregate gross proceeds.
- Sales occurred from April 1, 2025, to July 31, 2026.
Price Impact
More from AIM